Amine M. Zaouali

Amine M. Zaouali

Auto-generated profile, based on publicly available information

Amine M. Zaouali

Service de dermatologie, hôpital Farhat-Hached, avenue Ibn El Jazzar, 4000 Sousse, Tunisie

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2010 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
AZAmine M. Zaouali
Amine M. Zaouali
SPSusagna Padrissa-Altés
Susagna Padrissa-Altés
IMIsmail Ben Mosbah
Ismail Ben Mosbah
IAIzabel Alfany-Fernandez
Izabel Alfany-Fernandez
MMMarta Massip-Salcedo
Marta Massip-Salcedo
Carmen PeraltaCarmen Peralta
Carmen Peralta
This study examined the effects of epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) supplementation to University of Wisconsin solution (UW) in steatotic and nonsteatotic livers during cold storage. Hepatic injury and function were evaluated in livers preserved for 24 hours at 4°C in UW and in UW with EGF and IGF-I (separately or in combination) and then perfused ex vivo for 2 hours at 37°C. AKT was inhibited pharmacologically. In addition, hepatic injury and survival were evaluated in recipients who underwent transplantation with steatotic and nonsteatotic livers preserved for 6 hours in UW and UW with EGF and IGF-I (separately or in combination). The results, based on isolated perfused liver, indicated that the addition of EGF and IGF-I (separately or in combination) to UW reduced hepatic injury and improved function in both liver types. A combination of EGF and IGF-I resulted in hepatic injury and function parameters in both liver types similar to those obtained by EGF and IGF-I separately. EGF increased IGF-I, and both additives up-regulated AKT in both liver types. This was associated with glycogen synthase kinase-3β (GSK3β) inhibition in nonsteatotic livers and PPARγ overexpression in steatotic livers. When AKT was inhibited, the effects of EGF and IGF-I on GSK3β, PPARγ, hepatic injury and function disappeared. The benefits of EGF and IGF-I as additives in UW solution were also clearly seen in the liver transplantation model, because the presence of EGF and IGF-I (separately or in combination) in UW solution reduced hepatic injury and improved survival in recipients who underwent transplantation with steatotic and nonsteatotic liver grafts. In conclusion, EGF and IGF-I may constitute new additives to UW solution in steatotic and nonsteatotic liver preservation, whereas a combination of both seems unnecessary. Liver Transpl 16:1098-1111, 2010. © 2010 AASLD.

1 October 2014 in Annales de Dermatologie et de Vénéréologie
Verified
Journal Article
Closed access
WSW. Saidi
W. Saidi
IHI. Hamrouni
I. Hamrouni
MCM. Chemli
M. Chemli
MLM. Larif
M. Larif
AZA. Zaouali
A. Zaouali
RNR. Nouira
R. Nouira